Mexico Mice Model Market (2025-2030)
The Mexico Mice Model Market was valued at $5.26 Million in 2025 and projected to reach to $6.85 Million by 2030, representing a compound annual growth rate of CAGR 5.4%. Mexico's mice model market is positioned for steady growth as the country strengthens its biomedical research capabilities and pharmaceutical development infrastructure.
Mexico Mice Model Market Trends and Insights
- This steady expansion reflects Mexico's increasing investment in biomedical research and pharmaceutical development, driven by growing demand for preclinical testing models in the country's expanding healthcare and life sciences sectors.
- Mexico's position within Latin America positions it as a key hub for research institutions and contract research organizations seeking reliable animal models for drug discovery and development. The mice model market in Mexico is supported by strengthening regulatory frameworks and collaboration between academic institutions and private research facilities throughout the country.
- Between 2025 and 2030, Mexico is expected to see enhanced adoption of genetically modified mouse models and specialized breeding facilities that meet international standards.
- Mexico's growing pharmaceutical manufacturing base and increasing focus on personalized medicine are key factors driving demand for advanced preclinical research tools, positioning the country as an emerging market for mice model suppliers and research service providers..
Key Market Statistics
- CAGR (2025-2030) CAGR 5.4%
- Market Size, 2025 ~USD 5.26 Million
- Forecast, 2030 ~USD 6.85 Million
- Country Mexico
Mexico Mice Model Market Overview
Market Size & Growth :
Mexico's mice model market is valued at $5.26 million in 2025, with projected growth to $6.85 million by 2030, demonstrating a steady 5.4% CAGR driven by expanding biomedical research initiatives.
Biomedical Research Expansion :
Mexico is experiencing increased investment in biomedical research infrastructure, with universities and research institutions expanding preclinical testing capabilities and demand for laboratory animal models.
Pharmaceutical Development Growth :
The Mexican pharmaceutical sector is accelerating drug development activities, creating heightened demand for mice models in preclinical testing phases and regulatory compliance requirements.
Healthcare Sector Modernization :
Mexico's growing healthcare and life sciences sector is modernizing research standards, increasing adoption of standardized mice models for disease research and therapeutic development.
Mexico Mice Model Market Dynamics
- The 5.4% CAGR reflects increasing institutional investment in preclinical research and growing collaboration between Mexican research institutions and international pharmaceutical companies.
- Government initiatives supporting life sciences innovation and regulatory harmonization with international standards are expected to drive market expansion.
- The market will benefit from rising demand for cost-effective preclinical testing solutions and Mexico's strategic position as a regional research hub in Latin America..
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- Mexico's mice model market is valued at $5.26 million in 2025 and will reach $6.85 million by 2030 at a 5.4% CAGR.
- Mexico is emerging as a regional hub for preclinical research with growing adoption of genetically modified mouse models.
- Strengthening regulatory frameworks and academic-industry collaboration are driving market expansion in Mexico.
- Mexico's pharmaceutical manufacturing growth and personalized medicine focus are key demand drivers for mice models through 2030.
Mice Model Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | SERVICES (Model Type & Service) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 10% from 2025 to 2030 |
| Largest Segment | MODEL TYPE (Model Type & Service) |
| Market Size Base Year (Billions) | ~USD 1.7 (2025) |
| Revenue Forecast (Billions) | ~USD 2.74 (2030) |
| Segments Covered | Model Type & Service, Type, Technology, Application, Therapeutic Area |
Mexico Mice Model Market Report Segmentation
5 segment dimensions are covered across the global market.
By Model Type & Service
- Model Type
- Services
By Type
- Breeding Services
- Cryopreservation Services
- Genetically Engineered Mice
- Hybrid/Congenic Mice
- Inbred Mice
- Other Services
- Outbred Mice
- Quarantine Services
- Rederivation Services
By Technology
- Crispr/Cas9
- Embryonic Stem Cell Injections
- Microinjections
- Nuclear Transfer Technique
- Other Technologies
By Application
- Drug Discovery & Development
- Personalized Medicine
- Research Applications
By Therapeutic Area
- Cardiovascular Diseases
- Immunology
- Metabolic Diseases
- Neurology
- Oncology
- Other Therapeutic Areas
Target Audience
- Pharmaceutical Companies : Mexican and international pharmaceutical firms need market data to plan preclinical research operations, establish testing facilities, and allocate resources for drug development in Mexico.
- Research Institutions : Universities and biomedical research centers require market insights to justify funding requests, benchmark capabilities, and identify collaboration opportunities in Mexico's growing research ecosystem.
- Laboratory Animal Suppliers : Mice breeding facilities and animal model providers need Mexico-specific demand forecasts to optimize supply chains, expand operations, and capture market share in the region.
- Healthcare Investors : Private equity and venture capital firms evaluating life sciences investments in Mexico need detailed market analysis to assess growth potential and identify promising portfolio companies.
- Regulatory & Compliance Bodies : Government agencies and regulatory organizations need market data to develop policies, establish standards, and support Mexico's biomedical research infrastructure development.
Key Companies in the Mexico Mice Model Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| HORIZON DISCOVERY GROUP PLC | United Kingdom | Private Company | Screening,Research Reagents,Diagnostics, |
| LABORATORY CORPORATION OF AMERICA HOLDINGS | United States | Public Company | Routine and wellness diagnostics (chemistry, hematology, urinalysis, wellness programs),Specialty and esoteric testing (gene-based, oncology, infectious disease, women’s health, pharmacogenetics),Biopharma Laboratory Services (clinical trial, central lab, medical device and diagnostic R&D), |
| CHARLES RIVER LABORATORIES | United States | Public Company | Discovery and Safety Assessment,Research Models and Services,Manufacturing Solutions, |
| THE JACKSON LABORATORY | United States | Foundation/Charitable Institution | Mouse breeding and colony management services,Cryopreservation, recovery, and genetic resource management,Phenotyping, efficacy testing, and study-ready induced models, |
| INOTIV | United States | Public Company | Research Models and Services (RMS),Discovery and Safety Assessment (DSA) Services,BASi Scientific Instruments and Software, |
| JSR CORPORATION | Japan | Private Company | Digital Solutions (lithography, photoresists, packaging, CMP, display materials),Plastics (synthetic resins: ABS, AES, AS, ASA),Life Sciences (diagnostic reagents, bioprocess materials, drug discovery support), |
| BIOCYTOGEN | China | Public Company | Gene-Editing Services,Pharmacological Efficacy & Toxicology Services,Model Animals (Breeding & Sales), |
| SHANGHAI MODEL ORGANISMS CENTER, INC. | China | Public Company | Standard and disease mouse models (including toolbox and disease-specific strains),Customized genetically engineered models (KO, KI, humanized, transgenic),Preclinical services (non-GLP tox, PK, pharmacology/PD, phenotype analysis), |
| TRANS GENIC INC. | Japan | Public Company | Drug Discovery Support (non-clinical, bioequivalence, safety tests),Transgenic Models & Reagents (GM mice, antibodies, proteins, cells),Glycan Synthesis & Sugar Chain Analysis, |
| HARBOUR BIOMED | China | Public Company | Harbour Mice platform licensing and collaborations,Immunology clinical assets (e.g., batoclimab, HBM7020, HBM9378),Oncology clinical assets (e.g., porustobart, solid tumor portfolio), |
| GENOWAY | France | Public Company | Custom KO/KI mouse models,Custom KO/KI rat models,Humanized and immunodeficient rodent models (catalog and custom), |
| GEMPHARMATECH | China | Public Company | Standard GEMM catalog (knockout, conditional, knock-in, point-mutation, transgenic),Custom model generation and tool mice,Preclinical testing services, |
| VIVO BIO TECH LTD. | India | Public Company | In vivo and in vitro toxicity, PK/TK, and pharmacology services,SPF lab animals, rodent breeding, custom models, and lab diets,Genotoxicity screening and analytical services, |
HORIZON DISCOVERY GROUP PLC
Horizon Discovery Group PLC is a United Kingdom-based private company founded in 2005 with 428 employees. The company operates in the life sciences sector, providing specialized research and development services.
LABORATORY CORPORATION OF AMERICA HOLDINGS
Laboratory Corporation of America Holdings is a major United States public company founded in 1995 with 66,385 employees. It is a leading provider of clinical laboratory services and drug development support.
CHARLES RIVER LABORATORIES
Charles River Laboratories is a United States public company founded in 1947 with 19,000 employees. The company provides preclinical and clinical laboratory services, research models, and safety assessment services.
THE JACKSON LABORATORY
The Jackson Laboratory is a United States foundation and charitable institution founded in 1929 with 2,100 employees. It is a premier research institution specializing in mammalian genetics and genomics.
INOTIV
Inotiv is a United States public company founded in 1974 with 1,996 employees. The company provides research models, services, and products for the pharmaceutical and biotechnology industries.
JSR CORPORATION
JSR Corporation is a Japan-based private company founded in 1948 with 7,997 employees. The company operates in advanced materials and life sciences sectors.
BIOCYTOGEN
Biocytogen is a China-based public company founded in 2008 with 1,443 employees. The company specializes in the development of genetically engineered animal models for research and drug development.
SHANGHAI MODEL ORGANISMS CENTER, INC.
Shanghai Model Organisms Center, Inc. is a China-based public company founded in 2000 with 848 employees. The company provides model organism services and products for biomedical research.
TRANS GENIC INC.
Trans Genic Inc. is a Japan-based public company founded in 1998 with 227 employees. The company develops and provides transgenic animal models for research applications.
HARBOUR BIOMED
Harbour Biomed is a China-based public company founded in 2016 with 272 employees. The company focuses on antibody and immunotherapy research and development.
GENOWAY
Genoway is a France-based public company founded in 1999 with 157 employees. The company specializes in the generation of genetically modified animal models for research.
GEMPHARMATECH
GemPharmatech is a China-based public company founded in 2017 with 1,590 employees. The company provides laboratory animal models and related research services.
VIVO BIO TECH LTD.
Vivo Bio Tech Ltd. is an India-based public company founded in 1987 with 174 employees. The company provides contract research services and laboratory animal models for pharmaceutical and biotechnology research.
Reasons to Buy this Report
- Market Entry Strategy : Gain detailed insights into Mexico's specific market dynamics, growth drivers, and competitive landscape to develop targeted market entry strategies and localized business plans.
- Investment Decision Support : Access comprehensive data on Mexico's 5.4% CAGR and market projections to evaluate investment opportunities in Mexican biomedical research and pharmaceutical development sectors.
- Competitive Positioning : Understand Mexico-specific demand patterns, institutional buyers, and regional competitors to position products and services effectively within the Mexican market.
- Regulatory & Compliance Insights : Identify Mexico-specific regulatory requirements, standards adoption, and compliance frameworks governing mice models and preclinical research practices.
- Growth Opportunity Identification : Discover emerging opportunities in Mexico's expanding pharmaceutical sector, research institutions, and healthcare modernization initiatives driving mice model demand.
Frequently asked questions
What is the current size of Mexico's mice model market?
Mexico's mice model market is estimated at $5.26 million in 2025 and is expected to grow to $6.85 million by 2030.
What is the projected growth rate for Mexico's mice model market?
Mexico's mice model market is projected to grow at a compound annual growth rate (CAGR) of 5.4% between 2025 and 2030.
What factors are driving growth in Mexico's mice model market?
Key drivers include Mexico's expanding pharmaceutical manufacturing base, increasing biomedical research investment, strengthening regulatory frameworks, and growing adoption of personalized medicine approaches.
How does Mexico's mice model market compare to the global market?
While Mexico's market grows at 5.4% CAGR, the global mice model market expands at 10% CAGR, indicating Mexico is a developing market with significant growth potential within Latin America.
What types of mice models are in demand in Mexico?
Mexico shows increasing demand for genetically modified mouse models and specialized breeding facilities that meet international standards for preclinical drug testing and research applications.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global mice model market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used primarily to identify & collect information for the extensive, technical, market-oriented, and commercial study. The secondary sources used for this study include the International Mouse Phenotyping Consortium (IMPC), Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC), European Molecular Biology Laboratory−European Bioinformatics Institute (EMBL-EBI), Swiss Laboratory Animal Science Association (SGV), Medical Research Council (MRC), Asian Mouse Mutagenesis Resource Association (AMMRA), Department of Biotechnology (DBT) (India), World Health Organization (WHO), United States Food and Drug Administration (US FDA), Annual Reports, SEC Filings, Investor Presentations, Research Journals, Press Releases, and financial statements. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate & validate the total size of the mice model market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
An animal model is a valuable resource in biomedical research, chosen for its ability to replicate certain aspects of biological processes or diseases observed in humans. A mouse model is a genetically engineered or naturally occurring mouse strain used in biomedical research to mimic human diseases or conditions. These models are valuable for their biological similarity to humans, ability to be genetically manipulated, and cost-effectiveness, enabling researchers to study disease mechanisms and test novel drug therapies efficiently. Mice share over 95% of human DNA and are biologically similar to humans, thereby being susceptible to similar diseases due to the genetic build-up.
Stakeholders
- Manufacturers & Distributors of Mice Models
- CROs & CDMOs
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Market Research & Consulting Firms
- Researchers & Scientists
- Regulatory Authorities & Institutes
Report Objectives
- To define, describe, and forecast the global mice model market based on model type & service, technology, therapeutic area, application, product end user, service end user, and region
- To provide detailed information regarding the leading factors driving the growth of the market (such as drivers, restraints, challenges, and opportunities)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall mice models market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- Track & analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the mice models market.
- To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the mice model market.
Get the Full Mice Model Market Report
Full forecast, segment splits, and company analysis for all Mice Model Market.
- US Mice Model Market
- Canada Mice Model Market
- Germany Mice Model Market
- UK Mice Model Market
- France Mice Model Market
- Italy Mice Model Market
- Spain Mice Model Market
- China Mice Model Market
- Japan Mice Model Market
- India Mice Model Market
- Australia Mice Model Market
- South Korea Mice Model Market
- Brazil Mice Model Market
- United Arab Emirates Mice Model Market
- Rest Of Europe Mice Model Market
- Rest Of The Asia Pacific Mice Model Market
- Rest Of Asia Pacific Mice Model Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report